BIOMAT Database Logo BIOMAT Database Logo

[Screening for alpha-thalassemia using DNA analysis]. 1988

P Beris, and D Grossiord, and A Hochmann, and L Zhu, and P A Miescher
Département de médecine, Hôpital cantonal universitaire de Genève.

alpha-thalassemia was sought by gene mapping in 258 subjects selected on the basis of origin (25%), microcytosis (7%), or origin and microcytosis combined (64%). Abnormal fragments (Xba I/probe alpha) were found in 58 cases (22.5%). Using other restriction enzymes it was possible to determine the genotype alpha-/aa in 39 patients and the genotype alpha-/alpha- in 13 patients; 2 patients also exhibited hemoglobin H (alpha-/--) disease. alpha triplication anti-3.7 kb was found in 2 subjects and zeta-thalassemia in 2 other samples. 57 out of 58 patients originated from the thalassemia belt or from Africa. alpha-thalassemia is the most frequent hemoglobinopathy (21% of patients at risk) and hematologically is characterized by microcytosis. The Hb A2 level is decreased only in the alpha-/-- form of the disease. The main advantage of diagnosing zeta-thalassemias and alpha triplications lies in the possible clinical implications in the event of association with other hemoglobinopathies or beta-thalassemia.

UI MeSH Term Description Entries
D008297 Male Males
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006443 Hemoglobin A2 An adult hemoglobin component normally present in hemolysates from human erythrocytes in concentrations of about 3%. The hemoglobin is composed of two alpha chains and two delta chains. The percentage of HbA2 varies in some hematologic disorders, but is about double in beta-thalassemia. A2, Hemoglobin
D006447 Hemoglobin H An abnormal hemoglobin composed of four beta chains. It is caused by the reduced synthesis of the alpha chain. This abnormality results in ALPHA-THALASSEMIA.
D006453 Hemoglobinopathies A group of inherited disorders characterized by structural alterations within the hemoglobin molecule. Hemoglobinopathy
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013789 Thalassemia A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. Thalassemias
D015183 Restriction Mapping Use of restriction endonucleases to analyze and generate a physical map of genomes, genes, or other segments of DNA. Endonuclease Mapping, Restriction,Enzyme Mapping, Restriction,Site Mapping, Restriction,Analysis, Restriction Enzyme,Enzyme Analysis, Restriction,Restriction Enzyme Analysis,Analyses, Restriction Enzyme,Endonuclease Mappings, Restriction,Enzyme Analyses, Restriction,Enzyme Mappings, Restriction,Mapping, Restriction,Mapping, Restriction Endonuclease,Mapping, Restriction Enzyme,Mapping, Restriction Site,Mappings, Restriction,Mappings, Restriction Endonuclease,Mappings, Restriction Enzyme,Mappings, Restriction Site,Restriction Endonuclease Mapping,Restriction Endonuclease Mappings,Restriction Enzyme Analyses,Restriction Enzyme Mapping,Restriction Enzyme Mappings,Restriction Mappings,Restriction Site Mapping,Restriction Site Mappings,Site Mappings, Restriction

Related Publications

P Beris, and D Grossiord, and A Hochmann, and L Zhu, and P A Miescher
Alpha-thalassemia carrier identification by DNA analysis in the screening for thalassemia.
December 1998, American journal of hematology,
P Beris, and D Grossiord, and A Hochmann, and L Zhu, and P A Miescher
Anti-zeta antibody screening for alpha-thalassemia using dried filter paper blood.
February 1994, Biochemical medicine and metabolic biology,
P Beris, and D Grossiord, and A Hochmann, and L Zhu, and P A Miescher
Screening for alpha-thalassemia. Correlation of hemoglobin H inclusion bodies with DNA-determined genotype.
October 1992, Archives of pathology & laboratory medicine,
P Beris, and D Grossiord, and A Hochmann, and L Zhu, and P A Miescher
Neonatal screening for alpha-thalassemia in southern Taiwan.
December 1992, Journal of the Formosan Medical Association = Taiwan yi zhi,
P Beris, and D Grossiord, and A Hochmann, and L Zhu, and P A Miescher
Screening for alpha-thalassemia in neonates. Routine erythrocyte measurements.
March 1987, American journal of clinical pathology,
P Beris, and D Grossiord, and A Hochmann, and L Zhu, and P A Miescher
Cord blood screening for alpha-thalassemia in northern Taiwan.
February 1988, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
P Beris, and D Grossiord, and A Hochmann, and L Zhu, and P A Miescher
High resolution DNA melting analysis: an application for prenatal control of alpha-thalassemia.
April 2010, Prenatal diagnosis,
P Beris, and D Grossiord, and A Hochmann, and L Zhu, and P A Miescher
[Genetic screening for alpha-thalassemia deletional determinants by GapPCR method].
November 2006, Rinsho byori. The Japanese journal of clinical pathology,
P Beris, and D Grossiord, and A Hochmann, and L Zhu, and P A Miescher
[Alpha-thalassemia in Puglia. II. Neonatal screening for Bart's hemoglobin].
April 1979, Bollettino della Societa italiana di biologia sperimentale,
P Beris, and D Grossiord, and A Hochmann, and L Zhu, and P A Miescher
Erythrocyte osmotic fragility test for screening of alpha-thalassemia-1 and beta-thalassemia trait in pregnancy.
September 2004, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
Copied contents to your clipboard!